Congressional Research Service Reports - 23,951 Matching Results
Search Results
- Abortion Law Development: A Brief Overview
- This report offers an overview of the development of abortion law from 1973 to the present. Beginning with a brief discussion of the historical background, the report analyzes the leading Supreme Court decisions over the past twenty-eight years, emphasizing particularly the landmark decisions in Roe and Doe, the Court’s shift in direction in Webster v. Reproductive Health Services and Planned Parenthood of Southeastern Pennsylvania v. Casey, and the Court’s most recent decision on abortion, Stenberg v. Carhart. The Court’s decisions on the constitutionality of restricting public funding for abortion are also discussed.
- Abortion: Legislative Response
- The primary purpose of this issue brief is to focus on the current legislative action in the 107th Congress with respect to abortion; however, understanding that legislation requires a review of the U. S. Supreme Court’s leading decisions concerning a woman’s right to choose whether to terminate her pregnancy. For a detailed discussion of the case law, see CRS Report 95-724, Abortion Law Development: A Brief Overview.
- Abortion: Legislative Response
- The primary purpose of this issue brief is to focus on the current legislative action in the 107th Congress with respect to abortion; however, understanding that legislation requires a review of the U. S. Supreme Court’s leading decisions concerning a woman’s right to choose whether to terminate her pregnancy. For a detailed discussion of the case law, see CRS Report 95-724, Abortion Law Development: A Brief Overview.
- Abortion: Legislative Response
- The primary purpose of this issue brief is to focus on the current legislative action in the 107th Congress with respect to abortion; however, understanding that legislation requires a review of the U. S. Supreme Court’s leading decisions concerning a woman’s right to choose whether to terminate her pregnancy. For a detailed discussion of the case law, see CRS Report 95-724, Abortion Law Development: A Brief Overview.
- Abortion: Legislative Response
- The primary focus of this issue brief is legislative action in the 107th Congress with respect to abortion. However, discussion of those legislative proposals necessarily involves a brief discussion of the leading U.S. Supreme Court decisions concerning a woman’s right to choose whether to terminate her pregnancy. For a more detailed discussion of the relevant case law, see CRS Report 95-724, Abortion Law Development: A Brief Overview.
- Abortion: Legislative Response
- The primary focus of this issue brief is legislative action in the 107th Congress with respect to abortion. However, discussion of those legislative proposals necessarily involves a brief discussion of the leading U.S. Supreme Court decisions concerning a woman’s right to choose whether to terminate her pregnancy. For a more detailed discussion of the relevant case law, see CRS Report 95-724, Abortion Law Development: A Brief Overview.
- Abortion: Legislative Response
- The primary focus of this issue brief is legislative action in the 108th Congress with respect to abortion. However, discussion of those legislative proposals necessarily involves a brief discussion of the leading U.S. Supreme Court decisions concerning a woman’s right to choose whether to terminate her pregnancy. For a more detailed discussion of the relevant case law, see CRS Report 95-724, Abortion Law Development: A Brief Overview.
- Abortion: Legislative Response
- The primary focus of this issue brief is legislative action in the 108th Congress with respect to abortion. However, discussion of those legislative proposals necessarily involves a brief discussion of the leading U.S. Supreme Court decisions concerning a woman’s right to choose whether to terminate her pregnancy. For a more detailed discussion of the relevant case law, see CRS Report 95-724, Abortion Law Development: A Brief Overview.
- Abortion: Legislative Response
- The primary focus of this issue brief is legislative action in the 108th Congress with respect to abortion. However, discussion of those legislative proposals necessarily involves a brief discussion of the leading U.S. Supreme Court decisions concerning a woman’s right to choose whether to terminate her pregnancy. For a more detailed discussion of the relevant case law, see CRS Report 95-724, Abortion Law Development: A Brief Overview.
- Abortion: Legislative Response
- The primary focus of this issue brief is legislative action in the 108th Congress with respect to abortion. However, discussion of those legislative proposals necessarily involves a brief discussion of the leading U.S. Supreme Court decisions concerning a woman’s right to choose whether to terminate her pregnancy. For a more detailed discussion of the relevant case law, see CRS Report 95-724, Abortion Law Development: A Brief Overview.
- Abortion: Legislative Response
- The primary focus of this issue brief is legislative action in the 108th Congress with respect to abortion. However, discussion of those legislative proposals necessarily involves a brief discussion of the leading U.S. Supreme Court decisions concerning a woman’s right to choose whether to terminate her pregnancy. For a more detailed discussion of the relevant case law, see CRS Report 95-724, Abortion Law Development: A Brief Overview.
- Abortion: Legislative Response
- The primary focus of this issue brief is legislative action in the 108th Congress with respect to abortion. However, discussion of those legislative proposals necessarily involves a brief discussion of the leading U.S. Supreme Court decisions concerning a woman’s right to choose whether to terminate her pregnancy. For a more detailed discussion of the relevant case law, see CRS Report 95-724, Abortion Law Development: A Brief Overview.
- Abortion: Legislative Response
- The primary focus of this issue brief is legislative action in the 108th Congress with respect to abortion. However, discussion of those legislative proposals necessarily involves a brief discussion of the leading U.S. Supreme Court decisions concerning a woman’s right to choose whether to terminate her pregnancy. For a more detailed discussion of the relevant case law, see CRS Report 95-724, Abortion Law Development: A Brief Overview.
- Partial-Birth Abortion: Recent Developments in the Law
- No Description Available.
- Partial-Birth Abortion: Recent Developments in the Law
- No Description Available.
- Partial-Birth Abortion: Recent Developments in the Law
- No Description Available.
- Partial-Birth Abortion: Recent Developments in the Law
- No Description Available.
- Partial-Birth Abortion: Recent Developments in the Law
- No Description Available.
- Abortion: Termination of Early Pregnancy with RU-486 (Mifepristone)
- On September 28, 2000, the Food and Drug Administration (FDA) approved the drug mifepristone, also known as RU-486, for the termination of early pregnancy. Because RU-486 is an abortion agent, the process of moving it out of the lab and into mainstream medicine has been fraught with controversy. Since its discovery, the pro-life movement has been adamantly against the use of this drug for abortion. This report discusses the procedure of obtaining and using the drug, as well as the ongoing debate regarding its usage and related legislation.
- Older Americans Act: Programs and Funding
- Report on the programs and funding for social and nutrition services for older persons, including a list of the programs, grants, elder rights, and more.
- Medicare: Prescription Drug Proposals
- This report provides an overview of the President’s plan and the legislation introduced to date in the 106th Congress. It
- Medicare Beneficiary Access to Care: The Effects of New Prospective Payment Systems on Outpatient Hospital Care, Home Health Care, and Skilled Nursing Facility Care
- This report discusses the Balanced Budget Act of 1997 (BBA 97), which required that prospective payment systems replace retrospective cost-based reimbursement systems for Medicare beneficiaries receiving care in hospital outpatient departments, from home health care agencies, and in skilled nursing facilities.
- Military Technicians: The Issue of Mandatory Retirement for Non-Dual-Status Technicians
- This report describes the mandatory retirement provisions for certain “non-dual-status” military technicians contained in the National Defense Authorization Act for Fiscal Year 2000 (P.L. 106-65), discusses the stated rationale behind the policy, and quantifies the impact it will likely have on individual technicians.
- Medicare: Selected Prescription Drug Proposals
- Report on selected prescription drug proposals in the Medicare program, including a cost benefits analysis, summary of proposals, background of the issues, and more.
- Medicare+Choice Payments
- This report discusses the M+C program that established new rules for beneficiary and plan participation. This report focuses on M+C payments.
- Medicare+Choice Payments
- This report discusses the M+C program that established new rules for beneficiary and plan participation. This report focuses on M+C payments.
- Medicare: Side-by-Side Comparison of Selected Prescription Drug Bills
- Report comparing prescription drug bills in the Medicare program, including an examination of the covered population, benefits, deductibles, premiums, and more.
- Older Workers: Employment and Retirement Trends
- No Description Available.
- Medicare Provisions in the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000 (BIPA, P.L. 106-554)
- No Description Available.
- Medicaid, SCHIP, and Other Health Provisions in H.R. 5661: Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000
- This report discusses Medicaid and the State Children’s Health Insurance Program (SCHIP). The report also discusses other major health provisions provisions of H.R. 5661 are incorporated, by reference into H.R. 4577, the Consolidated Appropriations Act 2001.
- Medicare Structure Reform: Background and Options
- No Description Available.
- Summary of the Medicare Regulatory and Contracting Reform Act of 2001 (H.R. 3391)
- No Description Available.
- Major Provisions of the Medicare Modernization and Prescription Drug Act of 2002, H.R. 4954, as Passed by the House
- No Description Available.
- Medicare: Beneficiary Cost-Sharing Under Prescription Drug Legislation
- This report provides an analysis of how the cost-sharing and premium provisions under the Prescription Drug and Medicare Improvement Act of 2003 (S. 1) and the Medicare Prescription Drug and Modernization Act of 2003 (H bill would affect the amount that a beneficiary would pay annually for prescription drugs.
- Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits
- This report examines these proposals as well as the “Medicare Rx Drug Benefit and Discount Act of 2003,” which was introduced by Representative Charles Rangel, the ranking member of the House Ways and Means Committee. Specifically, this report provides background on how the cost-sharing and premium provisions under each bill would affect the amount that a beneficiary pays annually for prescription drugs.
- Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits
- This report provides background on how the cost-sharing and premium provisions under each bill would affect the amount that a beneficiary pays annually for prescription drugs. In addition, this report gives examples of how annual cost-sharing would differ for beneficiaries with various levels of total prescription drug spending in 2006 under the plans.
- Medicare Prescription Drug and Reform Legislation
- This report describes the major features of S. 1, as ordered reported, and the measure to be considered by the House Ways and Means Committee, H.R. 2473, as ordered reported.
- Overview of the Medicare Prescription Drug and Reform Legislation
- No Description Available.
- Overview of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003
- No Description Available.
- Medicare Prescription Drug Provisions of S.1, as Passed by the Senate, and H.R. 1, as Passed by the House
- This report discusses differences in the specifics of the prescription drug provisions in S. 1 and H.R. 1 and provides a side-by-side comparison of the Title I provisions of both bills.
- Medicare's Skilled Nursing Facility Benefit
- No Description Available.
- Trends in Medicare Spending: Fact Sheet
- No Description Available.
- Tobacco Price Support: An Overview of the Program
- No Description Available.
- Conservation Reserve Program: Status and Current Issues
- The Conservation Reserve Program (CRP), enacted in 1985, enables producers to retire highly erodible or environmentally sensitive cropland, usually for 10 years. Congress reauthorized and amended the CRP in the 1996 Federal Agriculture Improvement and Reform Act (P.L. 104-127; 16 U.S.C. 3811, et seq.). The law caps enrollment at 36.4 million acres and makes funding mandatory through the commodity Credit Corporation.
- Conservation Reserve Program: Status and Current Issues
- The Conservation Reserve Program (CRP), enacted in 1985, enables producers to retire highly erodible or environmentally sensitive cropland, usually for 10 years. Congress reauthorized and amended the CRP in the 1996 Federal Agriculture Improvement and Reform Act (P.L. 104-127; 16 U.S.C. 3811, et seq.). The law caps enrollment at 36.4 million acres and makes funding mandatory through the commodity Credit Corporation.
- U.S. Agricultural Trade: Trends, Composition, Direction, and Policy
- No Description Available.
- U.S. European Agricultural Trade: Food Safety and Biotechnology Issues
- This report discusses the differences over food safety measures and biotechnology between U.S. and European Union (EU) in agricultural trade, particularly the EU's ban on meat produced using growth-promoting hormones and resulting contention in the World Trade Organization (WTO).
- Agricultural Trade Issues in the 106th Congress
- Agricultural interests have been following trade policy developments against a backdrop of weak foreign demand and large world supplies of agricultural products. The U.S. Department of Agriculture reports that the value of U.S. agricultural exports fell between FY1996 (a record year) and FY1999 by almost $11 billion. USDA forecasts agricultural exports at $50.5 billion in FY2000 and $51.5 billion in FY2001. However, the projected agricultural trade surpluses for those years, of $11.5 billion and $12 billion, would be less than half the FY1996 surplus of $27.2 billion. Many agricultural groups and their supporters in Congress believe that the sector's future prosperity depends upon such U.S. trade policies as: 1) encouraging China's entry into the World Trade Organization (WTO), with its binding rules and responsibilities; 2) exempting agriculture from U.S. unilateral economic sanctions; 3) fully using export and food aid programs; and 4) aggressively battling foreign-imposed barriers to the movement of U.S. farm products. A few U.S. farm groups are wary of such approaches.
- Farm Economic Relief: Issues and Options for Congress
- This report discusses issues regarding Agriculture funding, specifically the Federal Agriculture Improvement and Reform (FAIR) Act (P.L. 104-127), which prescribed farm commodity support policy through 2002.
- Farm Economic Relief: Issues and Options for Congress
- This report discusses issues regarding Agriculture funding and subsidies. In response to low prices, natural disasters, and other farm-related problems, Congress has, over 3 successive years, provided a total of about $23 billion in supplemental aid – in addition to funds already programmed through the 1996 farm bill (P.L. 104-127). The most recent aid was attached to a crop insurance reform bill signed into law on June 22, 2000 (P.L. 106-224). This Agriculture Risk Protection Act of 2000 includes $7.113 billion for additional farm income and related assistance, of which $5.5 billion is to be spent in FY2000.